References
Slomka PJ, Nishina H, Berman DS, Akincioglu C, Abidov A, Friedman JD, et al. Automated quantification of myocardial perfusion SPECT using simplified normal limits. J Nucl Cardiol 2005;12:66–77.
Germano G, Kavanagh PB, Waechter P, Areeda J, Van Kriekinge S, Sharir T, et al. A new algorithm for the quantification of myocardial perfusion SPECT. I: technical principles and reproducibility. J Nucl Med 2004;41:712–9.
Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, et al. incremental value of prognostic testing in patients with known and suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single photon emission computed tomography [published erratum appears in J Am Coll Cardiol 1996;27:756]. J Am Coll Cardiol 1995;26:639–47.
Garcia EV, Van Train K, Maddahi J. Quantification of rotational thallium-201 myocardial tomography. J Nucl Med 1985;26:17–26.
Maddahi J, Van Train KF, Prigent F, Garcia EV, Friedman J, Ostrzega E, et al. Quantitative single photon emission computerized thallium-201 tomography for the evaluation of coronary artery disease: optimization and prospective validation of a new technique. J Am Coll Cardiol 1989;14:1689–99.
Van Train KF, Areeda J, Garcia EV, Cooke CD, Maddahi J, Kiat H, et al. Quantitative same-day rest-stress technetium-99m-sesta- mibi SPECT: definition and validation of stress normal limits and criteria for abnormality. J Nucl Med 1993;34:1494–502.
Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93:905–14.
Dakik HA, Kleiman NS, Farmer JA, He ZX, Wendt JA, Pratt CM, et al. Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study, Circulation 1998;98:2017–23.
Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of ph- VEGF165 as sole therapy for myocardial ischemia. Circulation 1998;98:2800–4.
Neglia D, Sambuceti G, Giorgetti A, Bartoli M, Salvadori P, Sorace O, et al. Effects of long-term treatment with verapamil on left ventricular function and myocardial blood flow in patients with dilated cardiomyopathy without overt heart failure. J Cardiovasc Pharmacol 2000;36:744–50.
Van Belle E, Abolmaali K, Bauters C, McFadden EP, Lablanche JM, Bertrand ME. Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients. J Am Coll Cardiol 1999;34:476–85.
Faber TL, Galt JR, Chen J, Tsui BMW, Garcia EV. Detecting changes in myocardial perfusion. In: Lemke HU, Vannier MW, Inamura K, et al., editors. Computed Assisted Radiology and Surgery. Berlin: Springer-Verlag; 2002. p. 879–83.
Slomka PJ, Nishina H, Berman DS, Kang X, Friedman JD, Hayes SW, et al. Automatic quantification of myocardial perfusion stress-rest change: a new measure of ischemia. J Nucl Med 2004;45:183–91.
Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995;36:2138–47.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nichols, K.J., Akinboboye, O.O. One good turn deserves another. J Nucl Cardiol 12, 3–4 (2005). https://doi.org/10.1016/j.nuclcard.2004.11.001
Issue Date:
DOI: https://doi.org/10.1016/j.nuclcard.2004.11.001